SUTRO BIOPHARMA, INC. Public Float
SUTRO BIOPHARMA, INC. (STRO) had Public Float of $60.00 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $60.00M.
- 2024-06-30: Entity Public Float $237.80M.
- 2023-06-30: Entity Public Float $278.30M.
- 2022-06-30: Entity Public Float $250.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $60.00M 10-K · filed 2026-03-23 |
| 2024-06-30 | $237.80M 10-K · filed 2025-03-13 |
| 2023-06-30 | $278.30M 10-K · filed 2024-03-25 |
| 2022-06-30 | $250.70M 10-K · filed 2023-03-30 |
| 2021-06-30 | $849.90M 10-K · filed 2022-02-28 |
| 2020-06-30 | $261.10M 10-K · filed 2021-03-18 |
| 2019-06-28 | $235.60M 10-K · filed 2020-03-16 |
| 2018-09-27 | $214.40M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |